Dentsply (XRAY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Dentsply International (XRAY) reported $879 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 7.8%. EPS of $0.43 for the same period compares to $0.42 a year ago.The reported revenue represents a surprise of +3.22% over the Zacks Consensus Estimate of $851.55 million. With the consensus EPS estimate being $0.29, the EPS surprise was +48.28%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Dentsply performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Organic sales growth: -4.4% versus -8.4% estimated by five analysts on average. Revenues- United States: $302 million versus $305.67 million estimated by three analysts on average. Revenues- Rest of World: $215 million versus the three-analyst average estimate of $190.83 million. The reported number represents a year-over-year change of -2.7%. Revenues- Europe: $362 million versus the three-analyst average estimate of $356.44 million. The reported number represents a year-over-year change of -3.7%. Net sales- Connected Technology Solutions: $235 million versus $233.14 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -4.9% change. Net sales- Wellspect Healthcare: $74 million versus $74.82 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +4.2% change. Net sales- Essential Dental Solutions: $353 million versus $352.85 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -3% change. Net sales- Orthodontic and Implant Solutions: $217 million versus $193.98 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -19.9% change. Adjusted Operating Income- Connected Technology Solutions: $7 million compared to the $16.08 million average estimate based on two analysts. Adjusted Operating Income- Wellspect Healthcare: $26 million versus the two-analyst average estimate of $23.18 million. Adjusted Operating Income- Orthodontic and Implant Solutions: $37 million versus the two-analyst average estimate of $13.19 million. Adjusted Operating Income- Essential Dental Solutions: $135 million compared to the $117.25 million average estimate based on two analysts. View all Key Company Metrics for Dentsply here>>>Shares of Dentsply have returned +0.2% over the past month versus the Zacks S&P 500 composite's +11.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report DENTSPLY SIRONA Inc. (XRAY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks